Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Namuscla 167 mg hard capsules

Active Ingredient:
mexiletine hydrochloride
Company:  
Lupin Healthcare (UK) Ltd See contact details
ATC code: 
C01BB02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 02 Jun 2021
{pdf} View or print the patient leaflet as PDF
Lupin Healthcare (UK) Ltd
Company image
Address
The Urban Building, 2nd Floor, 3-9 Albert Street, Slough, SL1 2BE
WWW
www.lupinhealthcare.co.uk
Telephone
+44 (0)1565 751 378
Fax
+44 (0)1565 751 379
Medical Information Direct Line
+44 (0)1565 751 378 Option 1
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)1565 751 378
Medical Information Fax
+44(0) 1565 751 379
Stock Availability
+44 (0)1565 751 378